Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomised, double-blind, placebo-controlled phase 3 trial of Depigoid Grass / Birch Mix in allergic rhinitis/rhinoconjunctivitis
2008-002264-34Phase 3Completed
- Sponsor
- LETI Pharma
- Start
- Jun 2008
- Modality
- Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in allergic rhinitis (AR), allergic rhinoconjunctivitis (ARC) and asthma comparing Depigoid Grass / Birch Mix with Placebo (2 arms). Started Jun 2008; status: completed.
02
Drugs
Depigoid Grass + Birch Mix
03
Conditions
allergic rhinitis (AR)allergic rhinoconjunctivitis (ARC)asthma
Beyond the preview
Go deeper on 2008-002264-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002264-34.